A recent study found that adding just one ounce of walnuts to the typical American diet improves diet quality and increases intakes of under-consumed nutrients. Researchers analyzed data from nearly 8,000 Americans without a history of nut consumption, showing significant benefits for all life stages.
Eating two ounces of walnuts daily for 16 weeks improved self-reported mental health indicators, had a protective effect against academic stress, and aided sleep quality. Walnuts' bioactive nutrients and phytochemicals may underlie their beneficial effects on mental health.
Researchers found that eating walnuts early in life is associated with a lower risk of heart disease, obesity, and diabetes. The study suggests that walnuts may act as a 'bridge food' to promote healthy nutrition and lifestyle habits throughout life.
A six- to ten-week resistance training program significantly improved knee flexion peak torque and vastus lateralis thickness in older adults who received peanut protein supplementation, compared to those without. The study found that PP supplementation increased muscle strength and growth in untrained older individuals.
Consumers of frozen meals had higher daily intakes of dietary fiber, potassium, calcium and protein, while QSR consumers had lower intakes. Frozen meal eaters also consumed 253 fewer calories and 2.6 grams less saturated fat per day.
Small molecule SMN2 splicing modifiers effectively prevent deficits in SMA mouse models by increasing SMN protein production. The treatment also improves life span and normalizes body weight.
Consumers of frozen meals had lower calorie intakes and better Healthy Eating Index scores compared to those who ate at quick service restaurants. They also consumed more vegetables, including greens and beans, and whole grains.
Researchers at Roche have successfully developed a new technology called Brain Shuttle that efficiently transports investigational antibodies into the brain in preclinical models of Alzheimer's disease. The technology increased target engagement by over 50-fold compared to parent antibodies.
A new NIH-funded study found that group-based weight loss treatment, led by health professionals or peer counselors, is effective in helping overweight and obese adults lose significant weight. The study, conducted at Baruch College, shows that Weight Watchers participants lost more weight than those in the combined treatment approach.
Piramal Imaging will present data from five florbetaben studies, including a pivotal Phase III trial that will provide the basis for regulatory submission later this year. The company is developing an innovative and proprietary tracer portfolio to address major clinical needs in Alzheimer's disease and other conditions.